Navigation Links
Data study suggests cortisol could alleviate for chronic fatigue syndrome and fibromyalgia
Date:3/19/2008

LOS ANGELES March 19, 2008 Chronic fatigue syndrome (CFS) and fibromyalgia (FM) are two serious and debilitating diseases with no confirmed cause and limited treatment options. However, results of a new comprehensive literature study propose a simplified treatment process that could help alleviate symptoms for patients suffering from these diseases.

Kent Holtorf, M.D., medical director of the Holtorf Medical Group Center for Endocrine, Neurological and Infection related illness Torrance, Calif., is advising a simplified treatment process that may help alleviate CFS and FM symptoms. From an extensive review of more than 50 published studies that assessed adrenal function in CFS and FM patients, Dr. Holtorf found that that the majority of CFS and FM patients displayed abnormal adrenal function due to hypothalamic-pituitary dysfunction. The comprehensive review also showed that the majority of patients could be treated for this adrenal dysfunction. Dr. Holtorfs analysis, recently published in the Journal of Chronic Fatigue Syndrome, demonstrated that patients that were given cortisol as part of a multi-system treatment experienced significant improvement in their symptoms.

My review of existing studies suggests that a treatment protocol of early administration of cortisol may help improve and reduce the symptoms of chronic fatigue syndrome and fibromyalgia, said Dr. Holtorf. This research provides a new understanding that treating the known causes of illness in CFS and FM can improve the symptoms and quality-of-life of patients who suffer from these conditions.

CFS and FM primarily affect women in their 30s and 40s. According to the Centers for Disease Control and Prevention (CDC) more than one million Americans suffer from CFS while it is estimate that FM affects about 2 percent of the U.S. population. Unfortunately, both of these diseases are poorly understood by many physicians and there is no generally accepted test to accurately detect them. In addition, many CFS and FM patients express frustration because there is no clear treatment path for their conditions.

Dr. Holtorfs research was further confirmed in an observational study following the conditions of 500 patients from his clinic, where of the patients given cortisol as part of their treatment protocol:

  • 94 percent showed improvement by the fourth visit;
  • 75 percent noted significant improvement;
  • 62 percent reported substantial improvement; and
  • Energy levels and a general sense of well-being for patients doubled by the fourth visit.

The effectiveness of this multi-system treatment was further confirmed through the analysis of the cumulative findings of over 40 independent physicians and over 5,000 patients.

As shown in the Journal of Chronic Fatigue Syndrome study, cortisol doses of 5-to-15mg a day have been shown to be safe, with little or no associated risk while having the potential for significant benefit for CFS and FM patients.

Cortisol treatment carries significantly less risk and a greater potential for benefit than treatments considered to be the standard of care for both conditions, Dr. Holtorf explains.


'/>"/>

Contact: Julian Teixeira
julian.teixeira@zenogroup.com
202-965-7808
Edelman Public Relations
Source:Eurekalert

Related medicine news :

1. Evanston-Northwestern Study Proves Effectiveness of MRSA Screening to Reduce Hospital Infections
2. MTM Study Reports Improved Quality and Economic Outcomes Using Medication Management Systems Assurance Pharmaceutical Care System(TM)
3. New Healthcare Study Outlines Strategies to Increase Adoption of Home Health Monitoring Technologies
4. Neighborhoods play key role in how much people exercise, study says
5. Study Analyzed Long-Term SYMBICORT(R) Use in Children With Persistent Asthma
6. Cancer detected earlier, faster, with new medical imaging, Stanford study finds
7. Study Finds Potential Cause of Age-Related Macular Degeneration
8. New Study: Pycnogenol(R) Improves Memory in Elderly
9. Researchers study new drug and indications for heated chemotherapy treatment
10. Scripps research team wins $4M grant to study effects of chronic marijuana use
11. Meditation impacts blood pressure, study shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... May 27, 2016 , ... With a ... medical and food industries. Aside from its GMP accreditation, Validation Center is also ... successfully certified products, services and staff. , Validation Center is ISO17025 accredited and ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways ... and Sausage Council (NHDSC) suggests that Americans prefer their dogs straight off the grill. ... say grilling is their favorite way to cook a hot dog, far outpacing other ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, and ... according to court documents and SEC filings. A jury has returned a ... American Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury awarded ...
(Date:5/26/2016)... Georgia (PRWEB) , ... May 26, 2016 , ... ... certificate in intellectual property (IP) to its specialty academic programs. , Answering to ... the college’s existing certificate programs in health law, and environmental and land use ...
(Date:5/26/2016)... ... May 26, 2016 , ... On Memorial Day, Hope For Heroes ... lives in military battle for the country. The nonprofit Hope For Heroes partnered ... programs that empower independence for disabled military veterans, as well as police, firemen, and ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... York , May 26, 2016 ... Research "Medical Waste Management Market - U.S. Industry Analysis, Size, ... waste management market in the U.S. was valued at US$ ... a CAGR of 3.4% from 2015 to 2023 to reach ... exhaustive analysis of current and emerging needle free drug delivery ...
(Date:5/25/2016)... , May 25,2016 ... the near-infrared Cellvizio platform for urological and surgical ... OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal ... regulatory milestone in the US with the 12 ... and Drug Administration (FDA). This new FDA clearance ...
(Date:5/25/2016)... YORK , May 25, 2016  According to ... reached $381 billion in 2015.  Though these are ... plenty of opportunity for success for companies that ... in search of new growth prospects medical device ... on research and development (R&D) than do companies ...
Breaking Medicine Technology: